TELA Bio to Announce Third Quarter 2026 Financial Results

What happened

TELA Bio, a commercial-stage medical technology company that makes soft-tissue reconstruction solutions, said it will report third quarter 2026 financial results on Tuesday, November 10, 2026, and will host a conference call and webcast at 4:30 p.m. ET that day.

Confirmed

Global impact / market context

The scheduled report gives investors a set date to see how much revenue TELA Bio earned and what it spent on running the business. Management's update on that call may also explain changes in sales, costs, and spending plans for soft-tissue products.

Analyst inference

TELA Bio is a small commercial-stage medical technology company, so its quarterly results can matter a lot to its stock price. Investors will compare revenue growth and cash available against the cost of selling its soft-tissue reconstruction products to hospitals and surgeons.

Analyst inference

What to watch

1. TELA Bio will release third quarter 2026 financial results on November 10, 2026, and management will hold a conference call and webcast at 4:30 p.m. ET that day. Confirmed
2. Listen for revenue from soft-tissue reconstruction products and for selling, general and administrative costs, which is spending on sales staff, marketing, and administration, because these drive whether TELA Bio moves toward profit. Analyst inference
3. Watch management's corporate update for any change in cash available, which is money on hand to fund operations, because a commercial-stage company depends on it to pay for sales growth and product development. Analyst inference

Evidence

• globenewswire.com